ReviewPathogens (Basel, Switzerland)2019
Persistence of
Review in Pathogens (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.
- A systematic review and meta-analysis of the prevalence of tick-borne SFGR in China from 2000 to 2022.PLoS neglected tropical diseases · 2024Pooled it
- Global meta-analysis onPathogens and global health · 2022Pooled it
- Pathogens of the Human Central Nervous System-the Major Protozoan Parasites and Helminths.Molecular neurobiology · 2026Review
- Computational immunoinformatics and molecular modeling approaches for designing a multi-epitope vaccine against Babesia microti.BMC microbiology · 2026Article
- Babesiosis and Its Significance in Transfusion Medicine from a European Point of View.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026Review
- From reservoirs to ecological integrators: the role of EuropeanFrontiers in veterinary science · 2026Review
- Human babesiosis: The past, present and future.Expert reviews in molecular medicine · 2025Review
- Increasing Length of theOpen forum infectious diseases · 2025Article
- A Highly Sensitive Multiplex Antibody Assay Reduces Window Period for Detection ofOpen forum infectious diseases · 2025Article
- Apoptosis and autophagy promoteFrontiers in microbiology · 2025Article
- Development of Multiplex Assays for the Identification of ZoonoticPathogens (Basel, Switzerland) · 2024Article
- Survey forInternational journal for parasitology. Parasites and wildlife · 2024Article
- Tumor Necrosis Factor Receptors and C-C Chemokine Receptor-2 Positive Cells Play an Important Role in the Intraerythrocytic Death and Clearance ofPathogens (Basel, Switzerland) · 2024Article
- Identification ofInfection and immunity · 2024Article
- Human Babesia odocoilei and Bartonella spp. co-infections in the Americas.Parasites & vectors · 2024Article
- Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG).PLoS neglected tropical diseases · 2024Article
- Coinfection ofPathogens (Basel, Switzerland) · 2024Review
- Immune Control in RepeatedOpen forum infectious diseases · 2024Article
- Prevalence and molecular detection of Babesia microti in rodents in Southeastern Shanxi, China.PloS one · 2024Article
- Protective efficacy and correlates of immunity of immunodominant recombinantInfection and immunity · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
Abstract
Persistent infection is a characteristic feature of babesiosis, a worldwide, emerging tick-borne disease caused by members of the genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.